Depreciation of NEUROCRINE BIOSCIENCES INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NEUROCRINE BIOSCIENCES INC annual and quarterly Depreciation in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEUROCRINE BIOSCIENCES INC Depreciation for the quarter ending 31 Mar 2025 was $6,600,000, a 25% increase year-over-year.
  • NEUROCRINE BIOSCIENCES INC annual Depreciation for 2025 was $26,000,000, a 11% increase from 2024.
  • NEUROCRINE BIOSCIENCES INC annual Depreciation for 2024 was $23,500,000, a 32% increase from 2023.
  • NEUROCRINE BIOSCIENCES INC annual Depreciation for 2023 was $17,800,000, a 18% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

NEUROCRINE BIOSCIENCES INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $26,000,000 +$2,500,000 +11% 01 Jan 2025 31 Dec 2025 10-K 11 Feb 2026 2025 FY
2024 $23,500,000 +$5,700,000 +32% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2026 2025 FY
2023 $17,800,000 +$2,700,000 +18% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2026 2025 FY
2022 $15,100,000 +$4,200,000 +39% 01 Jan 2022 31 Dec 2022 10-K 10 Feb 2025 2024 FY
2021 $10,900,000 +$2,300,000 +27% 01 Jan 2021 31 Dec 2021 10-K 09 Feb 2024 2023 FY
2020 $8,600,000 +$1,200,000 +16% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023 2022 FY
2019 $7,400,000 +$3,400,000 +85% 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
2018 $4,000,000 +$1,600,000 +67% 01 Jan 2018 31 Dec 2018 10-K 05 Feb 2021 2020 FY
2017 $2,400,000 +$900,000 +60% 01 Jan 2017 31 Dec 2017 10-K 07 Feb 2020 2019 FY
2016 $1,500,000 +$500,000 +50% 01 Jan 2016 31 Dec 2016 10-K 08 Feb 2019 2018 FY
2015 $1,000,000 +$200,000 +25% 01 Jan 2015 31 Dec 2015 10-K 13 Feb 2018 2017 FY
2014 $800,000 +$100,000 +14% 01 Jan 2014 31 Dec 2014 10-K 14 Feb 2017 2016 FY
2013 $700,000 $0 0% 01 Jan 2013 31 Dec 2013 10-K 11 Feb 2016 2015 FY
2012 $700,000 $0 0% 01 Jan 2012 31 Dec 2012 10-K 09 Feb 2015 2014 FY
2011 $700,000 -$700,000 -50% 01 Jan 2011 31 Dec 2011 10-K 11 Feb 2014 2013 FY
2010 $1,400,000 01 Jan 2010 31 Dec 2010 10-K 08 Feb 2013 2012 FY

NEUROCRINE BIOSCIENCES INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $6,600,000 +$1,300,000 +25% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q1 2024 $5,300,000 +$1,200,000 +29% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q1 2023 $4,100,000 +$800,000 +24% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q1 2022 $3,300,000 +$800,000 +32% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $2,500,000 +$400,000 +19% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $2,100,000 +$500,000 +31% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $1,600,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.